Related Experiment Video
Updated: Aug 5, 2026

Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
Pathogenesis of asthma
1Department of Medicine, University of Wisconsin Medical School, Madison.
Insights
Asthma management requires understanding its complex pathophysiology, focusing on inflammation and edema for chronic care, not just smooth muscle spasms. This approach aids in developing new asthma therapies.
Area of Science:
- Pediatric respiratory medicine
- Pulmonology
- Clinical immunology
Background:
- Asthma is a prevalent chronic lower respiratory condition in children.
- Understanding asthma pathophysiology is crucial for effective therapeutic management.
- A universally accepted definition of asthma remains elusive, complicating precise understanding.
Purpose of the Study:
- To emphasize the importance of comprehending asthma pathophysiology for optimal patient care.
- To highlight the multifactorial nature of airway obstruction in asthma.
- To underscore the significance of airway inflammation and edema in chronic asthma management.
Main Methods:
- Review of current understanding of asthma pathophysiology.
- Analysis of the role of bronchial smooth muscle spasm, inflammation, and edema.
- Utilizing the late-phase asthmatic response as a model for studying pathogenesis.
- Evaluating potential therapeutic strategies for chronic asthma management.
Main Results:
- Airway obstruction in asthma results from multiple interrelated factors.
- While smooth muscle spasm offers rapid relief, inflammation and edema require focus for chronic management.
- Asthma is increasingly recognized as an inflammatory lung disease.
Conclusions:
- Physicians must grasp the multifaceted pathophysiology of asthma for effective treatment.
- Therapeutic strategies should address both acute symptoms and underlying chronic inflammation.
- Further research into the late-phase asthmatic response can guide the development of novel asthma pharmaceuticals.
Abstract:
Asthma is the most common chronic lower respiratory tract condition in children. Thus, it is imperative that physicians caring for asthmatic patients understand the pathophysiology of asthma and its implications for optimal therapeutic management. A precise understanding of asthma pathophysiology has been impeded due to the fact that a universally acceptable definition for asthma has been difficult to formulate. Clinicians treating asthmatic patients should be aware that the airway obstruction present in these individuals is the result of multiple interrelated factors. Although bronchial smooth muscle spasm can be effectively treated producing rapid symptomatic relief, other factors contributing to airway obstruction, such as airway inflammation and edema, need to be a major focus of therapeutic strategies for more chronic management. While the concepts of reversibility and hyperresponsiveness have been appreciated for some time, the idea that asthma should be viewed as an inflammatory lung disease (or syndrome) has only recently received appropriate emphasis. In this regard, the late phase asthmatic response has provided a convenient model to study the biochemical and cellular interactions that contribute to the pathogenesis of asthma. Further, these responses will aid in the analysis of the potential beneficial effects of various pharmaceuticals as they undergo development and testing for use in asthmatic patients.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction
Asthma III: Clinical Manifestations

